加拿大安大略省 COVID-19 大流行对其子宫颈筛查计划、阴道镜检查和治疗服务的影响：一项基于人群的研究。

The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.

机构信息

Ontario Health (Cancer Care Ontario), Toronto, ON, Canada.

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

出版信息

BJOG. 2021 Aug;128(9):1503-1510. doi: 10.1111/1471-0528.16741. Epub 2021 May 31.

DOI:10.1111/1471-0528.16741

PMID:33982870

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8209864/

Abstract

OBJECTIVE

To describe the immediate impact of the COVID-19 pandemic on cervical screening, colposcopy and treatment volumes in Ontario, Canada.

DESIGN

Population-based retrospective observational study.

SETTING

Ontario, Canada.

POPULATION

People with a cervix age of 21-69 years who completed at least one cervical screening cytology test, colposcopy or treatment procedure for cervical dysplasia between January 2019 and August 2020.

METHODS

Administrative databases were used to compare cervical screening cytology, colposcopy and treatment procedure volumes before (historical comparator) and during the first 6 months of the COVID-19 pandemic (March-August 2020).

MAIN OUTCOME MEASURES

Changes in cervical screening cytology, colposcopy and treatment volumes; individuals with high-grade cytology awaiting colposcopy.

RESULTS

During the first 6 months of the COVID-19 pandemic, the monthly average number of cervical screening cytology tests, colposcopies and treatments decreased by 63.8% (range: -92.3 to -41.0%), 39.7% (range: -75.1 to -14.3%) and 31.1% (range: -43.5 to -23.6%), respectively, when compared with the corresponding months in 2019. Between March and August 2020, on average 292 (-51.0%) fewer high-grade cytological abnormalities were detected through screening each month. As of August 2020, 1159 (29.2%) individuals with high-grade screening cytology were awaiting follow-up colposcopy.

CONCLUSIONS

The COVID-19 pandemic has had a substantial impact on key cervical screening and follow-up services in Ontario. As the pandemic continues, ongoing monitoring of service utilisation to inform system response and recovery is required. Future efforts to understand the impact of COVID-19-related disruptions on cervical cancer outcomes will be needed.

TWEETABLE ABSTRACT

COVID-19 has had a substantial impact on cervical screening and follow-up services in Ontario, Canada.

摘要

目的

描述 COVID-19 大流行对加拿大安大略省宫颈筛查、阴道镜检查和治疗量的直接影响。

设计

基于人群的回顾性观察研究。

设置

加拿大安大略省。

人群

21-69 岁有子宫颈的人群，他们在 2019 年 1 月至 2020 年 8 月期间至少完成了一次宫颈筛查细胞学检查、阴道镜检查或治疗宫颈发育不良的程序。

方法

使用行政数据库比较 COVID-19 大流行前（历史对照）和前 6 个月（2020 年 3 月至 8 月）的宫颈筛查细胞学、阴道镜检查和治疗程序量。

主要观察指标

宫颈筛查细胞学、阴道镜检查和治疗量的变化；等待阴道镜检查的高级别细胞学异常患者。

结果

在 COVID-19 大流行的前 6 个月，与 2019 年同期相比，每月平均宫颈筛查细胞学检查、阴道镜检查和治疗量分别下降了 63.8%（范围：-92.3%至-41.0%）、39.7%（范围：-75.1%至-14.3%）和 31.1%（范围：-43.5%至-23.6%）。2020 年 3 月至 8 月期间，每月平均筛查出的高级别细胞学异常减少了 292 例（51.0%）。截至 2020 年 8 月，有 1159 例（29.2%）高级别细胞学筛查异常的患者等待后续阴道镜检查。

结论

COVID-19 大流行对安大略省的主要宫颈筛查和随访服务产生了重大影响。随着大流行的继续，需要对服务利用情况进行持续监测，以提供系统响应和恢复。未来还需要努力了解 COVID-19 相关中断对宫颈癌结局的影响。

推特摘要

COVID-19 对加拿大安大略省的宫颈筛查和随访服务产生了重大影响。

相似文献

The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.

BJOG. 2021 Aug;128(9):1503-1510. doi: 10.1111/1471-0528.16741. Epub 2021 May 31.

Performance measures related to colposcopy for canadian cervical cancer screening programs: identifying areas for improvement.

J Obstet Gynaecol Can. 2015 Mar;37(3):245-251. doi: 10.1016/S1701-2163(15)30310-8.

Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.

Elife. 2023 Jun 28;12:e83764. doi: 10.7554/eLife.83764.

Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.

Prev Med. 2021 Oct;151:106586. doi: 10.1016/j.ypmed.2021.106586.

Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.

J Obstet Gynaecol Can. 2019 Oct;41(10):1461-1469. doi: 10.1016/j.jogc.2019.02.007. Epub 2019 Apr 30.

Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.

JAMA. 2018 Aug 21;320(7):706-714. doi: 10.1001/jama.2017.19872.

A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.

BJOG. 2017 Sep;124(10):1585-1593. doi: 10.1111/1471-0528.14575. Epub 2017 Apr 12.

Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.

Gynecol Oncol. 2013 Jan;128(1):95-100. doi: 10.1016/j.ygyno.2012.10.006. Epub 2012 Oct 17.

Are there flaws in the follow-up of women with low-grade cervical dysplasia in Ontario?

J Obstet Gynaecol Can. 2014 Oct;36(10):892-899. doi: 10.1016/S1701-2163(15)30438-2.

Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.

J Med Screen. 2021 Jun;28(2):213-216. doi: 10.1177/09691413211001097. Epub 2021 Mar 17.

引用本文的文献

Exploring the role of the oncology nurse in cervical cancer screening programs during times of transition.

Can Oncol Nurs J. 2025 Jan 1;35(1):223-243. eCollection 2025 Winter.

Increasing Cervical Cancer Rates Among Women Age 35-54 Years in Canada: Age-Specific Cervical Cancer Incidence Trends in Canada, 1992-2022.

JCO Oncol Adv. 2025 Jul 9;2(1):e2400101. doi: 10.1200/OA-24-00101. eCollection 2025.

Changes in female cancer diagnostic billing rates over the COVID-19 period in the Ontario Health Insurance Plan.

Ther Adv Med Oncol. 2025 May 26;17:17588359251339919. doi: 10.1177/17588359251339919. eCollection 2025.

Healthcare use among cancer survivors during the COVID-19 pandemic: results from the SHARE COVID-19 Survey.

Support Care Cancer. 2024 Oct 10;32(11):718. doi: 10.1007/s00520-024-08885-6.

Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic.

Infect Agent Cancer. 2024 Aug 29;19(1):41. doi: 10.1186/s13027-024-00594-3.

Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia.

Front Oncol. 2024 May 29;14:1338859. doi: 10.3389/fonc.2024.1338859. eCollection 2024.

Cross-sectional study to assess the impact of the COVID-19 pandemic on healthcare services and clinical admissions using statistical analysis and discovering hotspots in three regions of the Greater Toronto Area.

BMJ Open. 2024 Mar 13;14(3):e082114. doi: 10.1136/bmjopen-2023-082114.

Impact of the Corona Pandemic on Cervical Cancer Screening Assessment.

In Vivo. 2024 Mar-Apr;38(2):734-740. doi: 10.21873/invivo.13495.

[Not Available].

CMAJ. 2023 Dec 10;195(48):E1674-E1701. doi: 10.1503/cmaj.230237-f.

Cancer Screening Disparities Before and After the COVID-19 Pandemic.

JAMA Netw Open. 2023 Nov 1;6(11):e2343796. doi: 10.1001/jamanetworkopen.2023.43796.

本文引用的文献

The feasibility and necessity of cancer screening events in the community during the COVID-19 pandemic in Taiwan.

J Med Screen. 2021 Mar;28(1):55-56. doi: 10.1177/0969141320941055. Epub 2020 Jul 16.

The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology.

Pathobiology. 2021;88(1):46-55. doi: 10.1159/000509546. Epub 2020 Jul 7.

Cytology in the time of coronavirus disease (COVID-19): an Italian perspective.

J Clin Pathol. 2021 Apr;74(4):261-263. doi: 10.1136/jclinpath-2020-206614. Epub 2020 Apr 20.

Recommendations on screening for cervical cancer.

CMAJ. 2013 Jan 8;185(1):35-45. doi: 10.1503/cmaj.121505. Epub 2013 Jan 7.

Colposcopic management of abnormal cervical cytology and histology.

J Obstet Gynaecol Can. 2012 Dec;34(12):1188-1202. doi: 10.1016/S1701-2163(16)35468-8.

An audit of the cervical cancer screening histories of 246 women with carcinoma.

J Low Genit Tract Dis. 2012 Jul;16(3):263-70. doi: 10.1097/LGT.0b013e31823da811.

How are women with high grade Pap smear abnormalities managed? A population based study.

Gynecol Oncol. 2011 Jun 1;121(3):499-504. doi: 10.1016/j.ygyno.2011.01.021. Epub 2011 Feb 26.

Cervical cancer prevention--cervical screening: science in evolution.

Obstet Gynecol Clin North Am. 2007 Dec;34(4):739-60, ix. doi: 10.1016/j.ogc.2007.09.004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

加拿大安大略省 COVID-19 大流行对其子宫颈筛查计划、阴道镜检查和治疗服务的影响：一项基于人群的研究。

The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.

机构信息

Ontario Health (Cancer Care Ontario), Toronto, ON, Canada.

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

出版信息

BJOG. 2021 Aug;128(9):1503-1510. doi: 10.1111/1471-0528.16741. Epub 2021 May 31.

DOI:10.1111/1471-0528.16741

PMID:33982870

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8209864/

Abstract

OBJECTIVE

To describe the immediate impact of the COVID-19 pandemic on cervical screening, colposcopy and treatment volumes in Ontario, Canada.

DESIGN

Population-based retrospective observational study.

SETTING

Ontario, Canada.

POPULATION

People with a cervix age of 21-69 years who completed at least one cervical screening cytology test, colposcopy or treatment procedure for cervical dysplasia between January 2019 and August 2020.

METHODS

MAIN OUTCOME MEASURES

Changes in cervical screening cytology, colposcopy and treatment volumes; individuals with high-grade cytology awaiting colposcopy.

RESULTS

CONCLUSIONS

TWEETABLE ABSTRACT

COVID-19 has had a substantial impact on cervical screening and follow-up services in Ontario, Canada.

摘要

目的

描述 COVID-19 大流行对加拿大安大略省宫颈筛查、阴道镜检查和治疗量的直接影响。

设计

基于人群的回顾性观察研究。

设置

加拿大安大略省。

人群

21-69 岁有子宫颈的人群，他们在 2019 年 1 月至 2020 年 8 月期间至少完成了一次宫颈筛查细胞学检查、阴道镜检查或治疗宫颈发育不良的程序。

方法

使用行政数据库比较 COVID-19 大流行前（历史对照）和前 6 个月（2020 年 3 月至 8 月）的宫颈筛查细胞学、阴道镜检查和治疗程序量。

主要观察指标

宫颈筛查细胞学、阴道镜检查和治疗量的变化；等待阴道镜检查的高级别细胞学异常患者。

结果

结论

推特摘要

COVID-19 对加拿大安大略省的宫颈筛查和随访服务产生了重大影响。

加拿大安大略省 COVID-19 大流行对其子宫颈筛查计划、阴道镜检查和治疗服务的影响：一项基于人群的研究。

The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.

机构信息

出版信息

OBJECTIVE

DESIGN

SETTING

POPULATION

METHODS

MAIN OUTCOME MEASURES

RESULTS

CONCLUSIONS

TWEETABLE ABSTRACT

目的

设计

设置

人群

方法

主要观察指标

结果

结论

推特摘要

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

加拿大安大略省 COVID-19 大流行对其子宫颈筛查计划、阴道镜检查和治疗服务的影响：一项基于人群的研究。

The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.

机构信息

出版信息

OBJECTIVE

DESIGN

SETTING

POPULATION

METHODS

MAIN OUTCOME MEASURES

RESULTS

CONCLUSIONS

TWEETABLE ABSTRACT

目的

设计

设置

人群

方法

主要观察指标

结果

结论

推特摘要